UW launches new research center to examine aging and age-related diseases
A new research center at the University of Wisconsin School of Medicine and Public Health will focus on understanding how metabolic changes associated with aging influence health and cause disease.
UW researchers tackle diabetes from multiple angles
Diabetes is a growing epidemic in Wisconsin. Its rise has been linked to limited access to healthy food and health care in some communities, lower levels of physical activity, and a rise in obesity, among other factors.
Radiopharmaceutical research agreement signed with NorthStar Medical Radioisotopes
A new agreement between the University of Wisconsin School of Medicine and Public Health and NorthStar Medical Radioisotopes, LLC (NorthStar) is aimed at advancing research and supporting workforce development in the nuclear medicine sector.
Q&A: Joshua Lang on new research on treatment-resistant prostate cancer
A five-year, $12.5 million grant has been awarded to researchers at UW–Madison to investigate metastatic, or advanced stage, prostate cancer, the second most common cause of cancer death in men.
Alzheimer’s blood test validated with help from UW–Madison data
The first blood plasma test to identify hallmarks of Alzheimer’s disease was cleared in May by the U.S. Food and Drug Administration (FDA), and University of Wisconsin researchers provided a portion of the samples used in the clinical validation test.
Q&A: Daniel Buckland on space medicine and medical technology
A space medicine fellowship, robots in the emergency room, and machine learning tools to improve clinical workflow are among the innovations Dr. Daniel Buckland, an associate professor in the BerbeeWalsh Department of Emergency Medicine, intends to explore within the University of Wisconsin School of Medicine and Public Health and UW’s College of Engineering, where he holds an affiliate governance appointment.
Diversifying UW’s research portfolio with federal defense, cybersecurity projects
A new campuswide effort seeks to build on existing relationships and develop closer ties between University of Wisconsin researchers and decisionmakers at the United States Department of Defense (DoD), defense-related industries, and other government partners focused on national security, like Sandia National Laboratories.
An early roadmap to preventing a devastating childhood brain cancer
Stopping genetic mutations that cause a rare but aggressive brain tumor in children may be the key to preventing the cancer’s development in the first place, according to researchers in the UW School of Medicine and Public Health.
Cell therapy for Parkinson’s shows promise
Parkinson’s patients are receiving a new investigational treatment thanks to groundbreaking research by Dr. Marina Emborg, a professor of medical physics in the University of Wisconsin School of Medicine and Public Health.
Understanding the effects of social media on teens
Hundreds of Wisconsin teens are helping UW researchers understand more about their online life, with potentially transformative results.
UW–Madison to lead nation in boron neutron capture therapy for cancer
The University of Wisconsin–Madison and TAE Life Sciences, a biotechnology company specializing in targeted radiation therapy for cancer care, have signed a memorandum of understanding, or MOU, announcing the intention to launch the first accelerator-based boron neutron capture therapy (BNCT) center in the United States.
Q&A: Jacques Galipeau on cell therapies to cure disease
Dr. Jacques Galipeau is the associate dean for therapeutics development and the director of the Program for Advanced Cell Therapy (PACT), a collaboration between UW Health and the University of Wisconsin School of Medicine and Public Health that aims to bring innovative cell therapies to patients. He is also a practicing hematologist, treating patients with blood clot disorders, anemia, and other diseases and conditions.